Literature DB >> 1686183

Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Effects of disease process and neuroleptic medication.

M D Simpson1, P Slater, M C Royston, J F Deakin.   

Abstract

The specific binding of [3H]TCP and [3H](+)3-PPP, radioligands which respectively label PCP-NMDA and sigma binding sites was measured in tissue homogenates prepared from dissected areas of control and schizophrenic postmortem brains. [3H]TCP binding was bilaterally increased in orbital frontal cortex (Brodmann area 11) of schizophrenic brains. This finding may be due to an increased glutamatergic innervation of orbital frontal cortex since it parallels our findings of increased [3H]kainate and [3H]D-aspartate binding in this area. In contrast, [3H](+)3-PPP binding was reduced in each of the four brain regions examined. The reductions were greatest in brains from the schizophrenic subjects receiving neuroleptics at the time of death. Neuroleptics remaining in the brains of these subjects may compete in vitro with [3H](+)3-PPP for binding to the sigma site.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686183     DOI: 10.1016/0920-9964(91)90019-n

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  9 in total

Review 1.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Authors:  Christine Konradi; Stephan Heckers
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

2.  Preclinical acute toxicity studies and dosimetry estimates of the novel sigma-1 receptor radiotracer, [18F]SFE.

Authors:  Rikki N Waterhouse; Jun Zhao; Michael G Stabin; Hanna Ng; Janice Schindler-Horvat; Raymond C Chang; Jon C Mirsalis
Journal:  Mol Imaging Biol       Date:  2006 Sep-Oct       Impact factor: 3.488

Review 3.  Is lead exposure in early life an environmental risk factor for Schizophrenia? Neurobiological connections and testable hypotheses.

Authors:  Tomás R Guilarte; Mark Opler; Mikhail Pletnikov
Journal:  Neurotoxicology       Date:  2011-12-09       Impact factor: 4.294

4.  Repeated administration of the novel antipsychotic olanzapine does not modulate NMDA-sensitive glutamate and 5HT2 serotonin receptors in rats.

Authors:  Ottavio Gandolfi; Manuela Voltattorni; Renato Gaggi; Rossella Dall'Olio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-05-13       Impact factor: 3.000

5.  Conventional and atypical antipsychotics in the elderly : a review.

Authors:  Pietro Gareri; Pasquale De Fazio; Mariagrazia Stilo; Guido Ferreri; Giovambattista De Sarro
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

6.  Glucocorticoid receptor mRNA and protein isoform alterations in the orbitofrontal cortex in schizophrenia and bipolar disorder.

Authors:  Duncan Sinclair; Maree J Webster; Janice M Fullerton; Cynthia Shannon Weickert
Journal:  BMC Psychiatry       Date:  2012-07-20       Impact factor: 3.630

7.  Rethinking schizophrenia in the context of normal neurodevelopment.

Authors:  Vibeke S Catts; Samantha J Fung; Leonora E Long; Dipesh Joshi; Ans Vercammen; Katherine M Allen; Stu G Fillman; Debora A Rothmond; Duncan Sinclair; Yash Tiwari; Shan-Yuan Tsai; Thomas W Weickert; Cynthia Shannon Weickert
Journal:  Front Cell Neurosci       Date:  2013-05-15       Impact factor: 5.505

8.  Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia.

Authors:  C S Weickert; S J Fung; V S Catts; P R Schofield; K M Allen; L T Moore; K A Newell; D Pellen; X-F Huang; S V Catts; T W Weickert
Journal:  Mol Psychiatry       Date:  2012-10-16       Impact factor: 15.992

9.  Postsynaptic density levels of the NMDA receptor NR1 subunit and PSD-95 protein in prefrontal cortex from people with schizophrenia.

Authors:  Vibeke Sørensen Catts; Dominique Suzanne Derminio; Chang-Gyu Hahn; Cynthia Shannon Weickert
Journal:  NPJ Schizophr       Date:  2015-10-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.